Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 07, 2016 11:08 PM ET

Company Overview of Department Of Health

Company Overview


United Kingdom

Key Executives for Department Of Health

Director General of Communications and Architect of Change 4 Life Healthy Living Campaign
Chief Nursing Officer
Deputy Chief Nursing Officer
Chairman of Pharmacy Programme Board
Compensation as of Fiscal Year 2015.

Department Of Health Key Developments

Department Of Health Presents at FT Global Pharmaceutical and Biotechnology Conference 2015, Nov-16-2015 10:50 AM

Department Of Health Presents at FT Global Pharmaceutical and Biotechnology Conference 2015, Nov-16-2015 10:50 AM. Venue: Marriott Hotel, Grosvenor Square, London W1K 6JP, United Kingdom. Speakers: Dame Sally Davies, Chief Medical and Chief Scientific Officer.

Department Of Health Reaches Agreement with GlaxoSmithKline plc on Meningitis Vaccine Bexsero

GlaxoSmithKline has reached an agreement with the United Kingdom's Department of Health (DoH) over the pricing of the firm's meningitis B vaccine Bexsero (meningococcal group-B vaccine [rDNA, component, adsorbed]). The vaccine will be added to the national childhood immunisation scheme, and babies will be immunised first at the age of two months, followed by two more doses.

GlaxoSmithKline Enters into Agreement with the UK Department of Health

GlaxoSmithKline (GSK) has entered into an agreement with the UK Department of Health to introduce a new vaccine to prevent meningitis caused by meningococcal group B bacteria for all babies in the country. The meningitis B vaccine will be introduced as part of the National Health Service's (NHS) NHS immunization program, which is scheduled to be initiated in September 2015. The vaccine will now be added to the national childhood immunization program, while babies will receive the first vaccine at two months old, followed by two further doses. The agreement offers fair value for the NHS and allows a reasonable return for the company to ensure that it can continue to invest in creating new treatments and vaccines.

Similar Private Companies By Industry

Company Name Region
Diamond Generating Europe Limited Europe
Bridge Bidco Ltd Europe
Carlyle Europe Ltd. Europe
Mydeo, Ltd. Europe
Residentsline Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Department Of Health, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at